WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE583.5527.75 (+4.99 %)
PREV CLOSE ( ) 555.80
OPEN PRICE ( ) 569.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 28767
TODAY'S LOW / HIGH ( )566.95 583.55
52 WK LOW / HIGH ( )145.35 630
NSE585.7027.85 (+4.99 %)
PREV CLOSE( ) 557.85
OPEN PRICE ( ) 578.00
BID PRICE (QTY) 585.70 (4226)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 682740
TODAY'S LOW / HIGH( ) 565.20 585.70
52 WK LOW / HIGH ( )145.15 630
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 08-07 1999
Management Info
Habil Khorakiwala - Chairman Murtaza Khorakiwala - Managing Director
Registered Office

Address D-4, M. I. D. C,Chikalthana, ,
Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006

Phone 0240-6632222 / 6694444

Email investorrelations@wockhardt.com

Website www.wockhardt.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, Luxembourg, MCX
NEWS
26Mar Allotment of Equity Shares
Inter alia, approved (Capital Rasing Committee) :- (i) approved the clo..
20Mar Allotment of Equity Shares
Inter alia, to consider and determine the issue price of Equity Shares t..
19Mar Wockhardt informs about closure of tra
Pursuant to Company’s ‘Code of Conduct for Regulating, Monitoring and Re..
26Feb Wockhardt informs about investor prese
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
19Jan Announcement under Regulation 30 (LOD
We wish to inform you that the Share Allotment Committee of the Board ha..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit-740-4660
Gross Profit -740 -5130
Operating Profit 3001370
Net Sales 288010720
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26946.00 (0.74%)
M.Cap (Rs. in Cr)57258.37
Sanofi India (BSE)
 8118.25 (2.06%)
M.Cap (Rs. in Cr)18696.83
Dr. Reddy's Lab (BSE)
 6155.15 (1.78%)
M.Cap (Rs. in Cr)102679.14
Divi's Lab (BSE)
 3436.75 (2.14%)
M.Cap (Rs. in Cr)91234.91
Glaxosmithkline Phar (BSE)
 1943.10 (3.26%)
M.Cap (Rs. in Cr)32917.29
Shareholding Pattern
PROMOTERS 54.93%
NON-INSTITUTION 40.59%
MUTUAL FUNDS/UTI 0.09%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.